Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Shares Outstanding (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed Shares Outstanding for 6 consecutive years, with $63.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding rose 2.41% year-over-year to $63.9 million, compared with a TTM value of $63.9 million through Dec 2025, up 2.41%, and an annual FY2025 reading of $63.9 million, up 2.41% over the prior year.
  • Shares Outstanding was $63.9 million for Q4 2025 at Treace Medical Concepts, roughly flat from $63.7 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $63.9 million in Q4 2025 and bottomed at $38.1 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $58.4 million, with a median of $61.6 million recorded in 2023.
  • The sharpest move saw Shares Outstanding skyrocketed 45.25% in 2022, then rose 0.99% in 2024.
  • Year by year, Shares Outstanding stood at $54.2 million in 2021, then rose by 2.67% to $55.6 million in 2022, then rose by 11.0% to $61.7 million in 2023, then rose by 0.99% to $62.4 million in 2024, then increased by 2.41% to $63.9 million in 2025.
  • Business Quant data shows Shares Outstanding for TMCI at $63.9 million in Q4 2025, $63.7 million in Q3 2025, and $63.0 million in Q2 2025.